Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate, Shares Surge 11.8%
Dyne Therapeutics narrows Q4 loss to $0.73/share vs $0.76 estimate, shares jump 11.8% on improving trajectory and $893M cash position.
ADVERTISEMENT
Earnings
BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit
BioNTech posts wider-than-expected Q4 loss of $0.33/share as COVID vaccine revenue plunges 24% year-over-year; founders to exit for new mRNA…
Sprinklr Inc (CXM) Beats Q4 FY26 EPS Estimates
Sprinklr Inc (CXM) delivered Q4 2025 adjusted earnings of $0.10 per share, surpassing analysts' $0.09 forecast (beat by 10.0%). Top-line…
Broadwind Energy Inc (BWEN) Reports Q4 Earnings
**Broadwind Energy Inc Reports Q4 2025 Results**
Pangaea Logistics Solutions Ltd (PANL) Reports Q4 Earnings
Pangaea Logistics Solutions Ltd (PANL) turned in Q4 2025 gaap EPS of $0.18, undershooting the $0.23 Street estimate (miss by…
SolarEdge (SEDG) Q4 Loss Narrows to $0.14/Share vs $0.24 Estimate, Stock Jumps 10%
SolarEdge narrows Q4 loss to $0.14/share vs $0.24 estimate, stock jumps 10% despite cautious Q1 guidance of $290M-$320M revenue.
Groupon Inc. (GRPN) Misses Q4 EPS Estimates
Groupon Inc (GRPN) posted Q4 2025 gaap EPS of $0.17, falling short of the $0.50 estimate (miss by 66.0%). Top-line…
CRISPR Therapeutics (CRSP) Reports Wider Q4 Loss of $1.37/Share on Zero Revenue; Shares Plunge 10%
CRISPR Therapeutics posts wider-than-expected Q4 loss of $1.37/share on zero revenue; shares sink 10% as cash burn accelerates.
Cadre Holdings, Inc. (CDRE) Misses Q4 EPS Estimates
**Cadre Holdings Reports Q4 2025 Earnings Miss**